Summit Therapeutics
SMMT
$3.66
Share price
-0.27%
Change (1 day)
128.44%
Change (1 year)
Categories
Revenue for Summit Therapeutics (SMMT)
Revenue in 2023 (TTM): N/A
a decrease over the years 2022 revenue that were of $0.7 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Summit Therapeutics from 2017 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | $0.7 M | -61.03% |
| 2021 | $1.8 M | |
| 2018 | $82.95 M | 350.46% |
| 2017 | $18.41 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.24 B | N/A | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | N/A | N/A | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.25 B | N/A | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | $0.37 M | N/A | 🇺🇸 USA |